Literature DB >> 30342157

Alternative respiratory chain enzymes: Therapeutic potential and possible pitfalls.

Sina Saari1, Geovana S Garcia2, Katharina Bremer3, Marina M Chioda4, Ana Andjelković5, Paul V Debes6, Mikko Nikinmaa7, Marten Szibor8, Eric Dufour9, Pierre Rustin10, Marcos T Oliveira11, Howard T Jacobs12.   

Abstract

The alternative respiratory chain (aRC), comprising the alternative NADH dehydrogenases (NDX) and quinone oxidases (AOX), is found in microbes, fungi and plants, where it buffers stresses arising from restrictions on electron flow in the oxidative phosphorylation system. The aRC enzymes are also found in species belonging to most metazoan phyla, including some chordates and arthropods species, although not in vertebrates or in Drosophila. We postulated that the aRC enzymes might be deployed to alleviate pathological stresses arising from mitochondrial dysfunction in a wide variety of disease states. However, before such therapies can be contemplated, it is essential to understand the effects of aRC enzymes on cell metabolism and organismal physiology. Here we report and discuss new findings that shed light on the functions of the aRC enzymes in animals, and the unexpected benefits and detriments that they confer on model organisms. In Ciona intestinalis, the aRC is induced by hypoxia and by sulfide, but is unresponsive to other environmental stressors. When expressed in Drosophila, AOX results in impaired survival under restricted nutrition, in addition to the previously reported male reproductive anomalies. In contrast, it confers cold resistance to developing and adult flies, and counteracts cell signaling defects that underlie developmental dysmorphologies. The aRC enzymes may also influence lifespan and stress resistance more generally, by eliciting or interfering with hormetic mechanisms. In sum, their judicious use may lead to major benefits in medicine, but this will require a thorough characterization of their properties and physiological effects.
Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AOX; Mitochondria; Mitochondrial disease; Reactive oxygen species; Thermogenesis

Mesh:

Substances:

Year:  2018        PMID: 30342157     DOI: 10.1016/j.bbadis.2018.10.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  7 in total

Review 1.  Targeting the alternative oxidase (AOX) for human health and food security, a pharmaceutical and agrochemical target or a rescue mechanism?

Authors:  Marten Szibor; Christina Schenkl; Mario R O Barsottini; Luke Young; Anthony L Moore
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

2.  Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active.

Authors:  Luca Giordano; Manish K Aneja; Natascha Sommer; Nasim Alebrahimdehkordi; Alireza Seraji; Norbert Weissmann; Carsten Rudolph; Christian Plank; Howard T Jacobs; Marten Szibor
Journal:  Gene Ther       Date:  2021-03-04       Impact factor: 5.250

3.  Alternative oxidase confers nutritional limitation on Drosophila development.

Authors:  Sina Saari; Esko Kemppainen; Tea Tuomela; Marcos T Oliveira; Eric Dufour; Howard T Jacobs
Journal:  J Exp Zool A Ecol Integr Physiol       Date:  2019-06-20

4.  Phenotypic effects of dietary stress in combination with a respiratory chain bypass in mice.

Authors:  Praveen K Dhandapani; Annina M Lyyski; Lars Paulin; Nahid A Khan; Anu Suomalainen; Petri Auvinen; Eric Dufour; Marten Szibor; Howard T Jacobs
Journal:  Physiol Rep       Date:  2019-08

5.  FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function.

Authors:  Lucia Trisolini; Nicola Gambacorta; Ruggiero Gorgoglione; Michele Montaruli; Luna Laera; Francesco Colella; Mariateresa Volpicella; Anna De Grassi; Ciro Leonardo Pierri
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

Review 6.  Thriving in Oxygen While Preventing ROS Overproduction: No Two Systems Are Created Equal.

Authors:  O Mendez-Romero; C Ricardez-García; P Castañeda-Tamez; N Chiquete-Félix; S Uribe-Carvajal
Journal:  Front Physiol       Date:  2022-04-04       Impact factor: 4.755

7.  Arabidopsis thaliana alternative dehydrogenases: a potential therapy for mitochondrial complex I deficiency? Perspectives and pitfalls.

Authors:  Alessia Catania; Arcangela Iuso; Juliette Bouchereau; Laura S Kremer; Marina Paviolo; Caterina Terrile; Paule Bénit; Allan G Rasmusson; Thomas Schwarzmayr; Valeria Tiranti; Pierre Rustin; Malgorzata Rak; Holger Prokisch; Manuel Schiff
Journal:  Orphanet J Rare Dis       Date:  2019-10-29       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.